Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
Molecular MRI is a powerful clinical tool for non-invasive detection of cancer biomarkers. Here, the authors develop a targeted peptide gadofullerene contrast agent that can sensitively distinguish between breast cancers of different aggressiveness.
Guardado en:
Autores principales: | Zheng Han, Xiaohui Wu, Sarah Roelle, Chuheng Chen, William P. Schiemann, Zheng-Rong Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1914b9cff54439aa02e8788099c7b2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
por: Zheng Han, et al.
Publicado: (2018) -
Ceramic resonators for targeted clinical magnetic resonance imaging of the breast
por: Alena Shchelokova, et al.
Publicado: (2020) -
Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging
por: Zijian Zhou, et al.
Publicado: (2020) -
The sensitivity of magnetic particle imaging and fluorine-19 magnetic resonance imaging for cell tracking
por: Olivia C. Sehl, et al.
Publicado: (2021) -
Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Christina Doesch, et al.
Publicado: (2017)